Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

Elke Boxhammer; Moritz Mirna; Laura Bäz; Nina Bacher; Albert Topf; Brigitte Sipos; Marcus Franz; Daniel Kretzschmar; Uta Hoppe; Alexander Lauten; Michael Lichtenauer

doi:10.3390/life12030389

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

Elke Boxhammer (Erstautor/-in), Moritz Mirna (Co-Autor/-in), Laura Bäz, Nina Bacher (Co-Autor/-in), Albert Topf (Co-Autor/-in), Brigitte Sipos (Co-Autor/-in), Marcus Franz, Daniel Kretzschmar, Uta Hoppe (Co-Autor/-in), Alexander Lauten, Michael Lichtenauer^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinik für Innere Medizin 2 - Kardiologie, Internistische Intensivmedizin und Notaufnahme

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

4 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	LIFE-BASEL
Jahrgang	12
Ausgabenummer	3
DOIs	https://doi.org/10.3390/life12030389
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.3390/life12030389

Dieses zitieren

@article{edc1ca3a43724a32a9c150df321d1da6,

title = "Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?",

keywords = "AORTIC-VALVE-REPLACEMENT, HEART-FAILURE, MORTALITY, PREDICTION, STENOSIS, IMPACT, IMPLANTATION, SUPPRESSION, SURVIVAL, OUTCOMES",

author = "Elke Boxhammer and Moritz Mirna and Laura B{\"a}z and Nina Bacher and Albert Topf and Brigitte Sipos and Marcus Franz and Daniel Kretzschmar and Uta Hoppe and Alexander Lauten and Michael Lichtenauer",

note = "Boxhammer, Mirna, Bacher, Topf, Sipos, Hoppe, Lichtenauer: Paracelsus Med Univ Salzburg, Dept Internal Med 2, Div Cardiol, A-5020 Salzburg, Austria",

year = "2022",

doi = "10.3390/life12030389",

language = "English",

volume = "12",

journal = "LIFE-BASEL",

issn = "2075-1729",